Itaconate confers tolerance to late NLRP3 inflammasome activation

Authors

Monika Bambouskova, Washington University School of Medicine in St. Louis
Lucie Potuckova, Washington University School of Medicine in St. Louis
Tomas Paulenda, Washington University School of Medicine in St. Louis
Martina Kerndl, Washington University School of Medicine in St. Louis
Denis A Mogilenko, Washington University School of Medicine in St. Louis
Amanda Swain, Washington University School of Medicine in St. Louis
Samantha Burdess, Washington University School of Medicine in St. Louis
Anwesha Laha, Washington University School of Medicine in St. Louis
Gaya K Amarasinghe, Washington University School of Medicine in St. Louis
Michael S Diamond, Washington University School of Medicine in St. Louis
Maxim N Artyomov, Washington University School of Medicine in St. Louis
et al

Journal

Cell Reports

Publication Date

3-9-2021

Volume

34

Issue

10

First Page

108756

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2021.108756

Rights and Permissions

Bambouskova M, Potuckova L, Paulenda T, Kerndl M, Mogilenko DA, Lizotte K, Swain A, Hayes S, Sheldon RD, Kim H, Kapadnis U, Ellis AE, Isaguirre C, Burdess S, Laha A, Amarasinghe GK, Chubukov V, Roddy TP, Diamond MS, Jones RG, Simons DM, Artyomov MN. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 2021 Mar 9;34(10):108756. doi: 10.1016/j.celrep.2021.108756. Copyright 2021 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Bambouskova, Monika; Potuckova, Lucie; Paulenda, Tomas; Kerndl, Martina; Mogilenko, Denis A; Swain, Amanda; Burdess, Samantha; Laha, Anwesha; Amarasinghe, Gaya K; Diamond, Michael S; Artyomov, Maxim N; and et al, "Itaconate confers tolerance to late NLRP3 inflammasome activation." Cell Reports. 34, 10. 108756 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10324